Innovation & Development

Statement, November 2017

Statement by the South Centre on EU-MERCOSUR Trade Negotiations

EU-MERCOSUR Trade Negotiations must not impose TRIPS Plus provisions on Protection and Enforcement of Intellectual Property Rights

(more…)

Research Paper 82, November 2017

The International Debate on Generic Medicines of Biological Origin

The debate on generic medicines is not new. What makes it different today is that attacks levelled against biological products are couched in ever more “technical” and abstruse language that confuses even the World Health Organization (WHO).

(more…)

SouthViews No. 156, 26 October 2017

Intellectual Property for the TwentyFirst-Century Economy

By Joseph E. Stiglitz , Dean Baker , Arjun Jayadev

Developing countries are increasingly pushing back against the intellectual property regime foisted on them by the advanced economies over the last 30 years. They are right to do so, because what matters is not only the production of knowledge, but also that it is used in ways that put the health and wellbeing of people ahead of corporate profits. (more…)

Policy Brief 45, October 2017

The Value Added of the United Nations General Assembly High–Level Political Declaration on Antimicrobial Resistance

In September 2016, the United Nations General Assembly (UNGA) in New York held a dedicated meeting to muster strong political commitment for an effective global response to the problem of antimicrobial resistance (AMR). As a result, a High-Level Political Declaration on Antimicrobial Resistance was adopted.

(more…)

Statement, October 2017

South Centre Statement to the Fifty-Seventh Series of Meetings of the Assemblies of the Member States of WIPO

The South Centre is participating in the WIPO Assemblies being held from 2 to 11 October 2017 in Geneva. Read the South Centre statement here.

(more…)